Stem Cells Spin S.A. (WSE:SCS)

Poland flag Poland · Delayed Price · Currency is PLN
0.4000
0.00 (0.00%)
At close: May 15, 2026
Market Cap16.53M +136.7%
Revenue (ttm)65.74K +21.1%
Net Income-517.99K
EPS-0.01
Shares Out41.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume30
Average Volume7,547
Open0.4000
Previous Close0.4000
Day's Range0.4000 - 0.4000
52-Week Range0.1510 - 0.5150
Beta0.43
RSI49.20
Earnings DateMay 15, 2026

About Stem Cells Spin

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wrocław, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O. [Read more]

Industry Biotechnology & Medical Research
Sector Healthcare
Founded 2009
Employees 1
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SCS
Full Company Profile

Financial Performance

In 2025, Stem Cells Spin's revenue was 65,736, an increase of 21.11% compared to the previous year's 54,280. Losses were -517,987, -0.44% less than in 2024.

Financial Statements